The CRA(s) in accordance with the sponsor’s ( the pharma company) requirements should ensure that the trial is conducted and documented properly by carrying out the necessary activities when relevant and necessary to the trial and the trial site.
CRA acts as the main line of communication between the sponsor and the investigator site. ( Hospital)
CRA Verifies that the investigator has adequate qualifications and resources and remain adequate throughout the trial period, facilities, including laboratories, equipment, and staff, is adequate to safely and properly conduct the trial and remain adequate throughout the trial period.
Pretty good post. I just stumbled upon your blog and wanted to say that I have really enjoyed reading your blog posts.
ReplyDeleteclinical research organization